Rorer
Executive Summary
Signs licensing agreement for transdermal estrogen system being developed by Miami, Fla.-based Noven Pharmaceuticals. The transdermal technology company plans to file an ANDA within the next few months for the generic version of Ciba-Geigy's Estraderm. Rorer retains worldwide marketing rights, excluding Japan, and has co-marketing agreement for U.S. and Canada.